Takeda Pharmaceutical Company Limited
Heterocyclic compound
Last updated:
Abstract:
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4. A compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
Status:
Grant
Type:
Utility
Filling date:
27 Jan 2020
Issue date:
13 Apr 2021